Tissue Repair & Recovery
BPC-157 — 20mg
Wolverine Stack$87
The higher-dose format of BPC-157 for research protocols requiring extended treatment windows or higher per-administration quantities of this gastric-derived pentadecapeptide.
Tissue Repair & RecoveryOverview
BPC-157 20mg provides researchers with a larger lyophilized batch of this well-characterized pentadecapeptide, enabling protocols that span longer durations or that explore dose-dependent outcomes without the interruption of frequent reorders. The compound itself is identical to the 10mg presentation — a synthetic 15-amino acid sequence derived from the partial sequence of human gastric juice BPC.
The higher vial quantity is particularly practical for studies involving multiple subjects, longitudinal dosing schedules, or comparative arms at different concentration ranges. Researchers investigating the FAK-paxillin pathway, VEGFR2-mediated angiogenesis, or GH receptor upregulation in fibroblast cultures will benefit from the uninterrupted supply this format provides.
All mechanistic data, safety observations, and research applications documented for BPC-157 apply equally here. The 2025 pilot IV safety data at 10–20mg is directly relevant to dosing ranges accessible with this vial size, and its FDA Category 2 bulk drug substance classification remains in effect regardless of batch size.
Mechanism of Action
Activates VEGFR2 for angiogenesis; mobilizes FAK-paxillin complexes for directed cell migration; upregulates GH receptor expression in fibroblasts to amplify downstream healing signals.
Research Applications
Areas of peer-reviewed scientific inquiry where this compound has appeared.
- Musculoskeletal injury and repair
- Gastrointestinal mucosal healing
- Neuroprotection and neural recovery
- Wound healing and tissue regeneration
- Anti-inflammatory modulation
Key Findings from the Literature
- 01Consistent tendon, ligament, and bone repair improvements in animal models
- 022025 pilot human IV study demonstrated safety at 10–20mg doses
- 03FDA Category 2 bulk drug substance — active area of clinical investigation
- 04Upregulates GH receptor density in fibroblasts without altering systemic hormone levels
Certificates of Analysis1
Independent third-party lab reports for this peptide. Each CoA can be verified against its accession number at the testing lab.
1 independent test by Freedom Diagnostics Testing
| Test | Result |
|---|---|
| Purity (HPLC) | 99.844% |
| Identity (MS) | Pass |
| Endotoxins (LAL) | Pass |
Lab: Freedom Diagnostics Testing
Accession: 2601290008 / 2601290009
Reports are verifiable against the issuing lab using the accession or batch identifier above.
Related Peptides
Other compounds in the tissue repair & recovery category.
tissue repairBPC-157
10mg
A 15-amino acid pentadecapeptide derived from human gastric juice, studied for its remarkable capacity to accelerate healing across musculoskeletal, gastrointestinal, and neural tissues.
tissue repairTB-500
10mg
A synthetic fragment of Thymosin Beta-4 corresponding to the actin-binding domain, extensively studied for its role in cardiac angiogenesis, soft tissue healing, and corneal regeneration.
tissue repairGHK-Cu
50mg
A naturally occurring copper-binding tripeptide found in human plasma, notable for its genomic reach — modulating approximately 4,000 human genes involved in tissue remodeling, growth factor expression, and anti-aging responses.